Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors
Cheryl T. Lee(The Ohio State University Wexner Medical Center), Victor E. Reuter(Memorial Sloan Kettering Cancer Center), Michael W. Kattan(Unknown), Paul Fearn(Memorial Sloan Kettering Cancer Center), Elizabeth M. Genega(Memorial Sloan Kettering Cancer Center), Brian Hutchinson(Joint Global Change Research Institute), Paul Russo(Memorial Sloan Kettering Cancer Center)
Cited by 34
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
|Nature Medicine|2019|2.6k
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|867